Shixia Huang

6.1k citations

70 papers · 3.7k indexed · 1 hit paper · h-index 30

Molecular Biology top 5%
Oncology top 2%
Cancer Research top 2%
Genetics top 5%
Pulmonary and Respiratory Medicine top 10%

Co-authors: Chad J. Creighton Joiner Cartwright Russell M. Lebovitz Ning Lü Hannes Vogel Henggui Zhang Martin M. Matzuk Anna Tsimelzon
Topics: Cancer Cells and Metastasis (14 papers)Epigenetics and DNA Methylation (6 papers)Wnt/β-catenin signaling in development and cancer (6 papers)
Cited by: Oncology Aging Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States China United Kingdom

In The Last Decade

Shixia Huang

65 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.

1996 822 citations Shixia Huang et al. profile →

Peers

Countries citing papers authored by Shixia Huang

Since Specialization

Citations

This map shows the geographic impact of Shixia Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shixia Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shixia Huang more than expected).

Fields of papers citing papers by Shixia Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shixia Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shixia Huang. The network helps show where Shixia Huang may publish in the future.

Co-authorship network of co-authors of Shixia Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Shixia Huang. A scholar is included among the top collaborators of Shixia Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shixia Huang. Shixia Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	eDNA Metabarcoding Reveals Homogenization of Fish in Fujiang Segments Isolated by Cascading Hydroelectric Stations 2025 ·Animals ·Chao Deng,Shixia Huang,Bolin Chen,(unknown),(unknown),(unknown),(unknown),Zhijian Wang,Xiaohong Liu	0
2	Epigenetic modifiers are altered with increased levels of polycyclic aromatic hydrocarbons (PAHs) 2023 ·American Journal of Obstetrics and Gynecology ·Melissa Suter,Grace Johnson,Sohini Banerjee,Shixia Huang,Bhagavatula Moorthy,Kjersti M. Aagaard	1
3	Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice 2023 ·Science Advances ·Wen Bu,Chad J. Creighton,(unknown),Carolina Gutiérrez,Yongchao Dou,Amy T. Ku,(unknown),Weiyu Jiang,(unknown),(unknown),Yue Fei,(unknown),Ahmed Atef Ibrahim,Bing Zhang,Shixia Huang,Yi Li	11
4	Dimethyl Sulfoxide Inhibits Bile Acid Synthesis in Healthy Mice but Does Not Protect Mice from Bile-Acid-Induced Liver Damage 2023 ·Biology ·(unknown),Huiqiao Li,Yue Liu,Jing Qi,Bingning Dong,Shixia Huang,Shangang Zhao,Yi Zhu	1
5	Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6 2022 ·Science Advances ·(unknown),Sriram Jayabal,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Shixia Huang,Alanna J. Watt	16
6	STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential 2022 ·Oncogene ·Meng Lin,Amy T. Ku,Jie Dong,Fei Yue,Weiyu Jiang,Ahmed Atef Ibrahim,Fanglue Peng,Chad J. Creighton,Chandandeep Nagi,Carolina Gutiérrez,Jeffrey M. Rosen,Xiang H.-F. Zhang,Susan G. Hilsenbeck,Xi Chen,Yi‐Chieh Nancy Du,Shixia Huang,Aiping Shi,Zhimin Fan,Yi Li	5
7	LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination 2022 ·Oncogene ·(unknown),Nino Rainusso,Meng Liu,Motonari Nomura,(unknown),Kengo Nakahata,Ha Ram Kim,Shixia Huang,Kimal Rajapakshe,Cristian Coarfa,Tsz‐Kwong Man,Pulivarthi H. Rao,Jason T. Yustein	19
8	A Wnt-Independent LGR4–EGFR Signaling Axis in Cancer Metastasis 2021 ·Cancer Research ·Yue Fei,Weiyu Jiang,Amy T. Ku,Adelaide I.J. Young,Weijie Zhang,(unknown),Yankun Gao,Zihan Yu,(unknown),Chad J. Creighton,Chandandeep Nagi,Tao Wang,Susan G. Hilsenbeck,Xin‐Hua Feng,Shixia Huang,Cristian Coarfa,Xiang H.-F. Zhang,Qingyun Liu,Xia Lin,Yi Li	16
9	Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways 2020 ·British Journal of Cancer ·(unknown),(unknown),(unknown),Sean Flynn,(unknown),Jing Zhang,Karen Messer,Qianxing Mo,Shixia Huang,Jacqueline Lesperance,Peter E. Zage	33
10	Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer 2020 ·Breast Cancer Research and Treatment ·Lei Xue,Fengju Chen,Yue Fei,Laura Camacho,(unknown),Guanyun Wei,Shixia Huang,Qianxing Mo,Fei Ma,Yi Li,Sao Jiralerspong	19
11	CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation 2018 ·Molecular Cancer Research ·Min Yao,Wei Bin Fang,(unknown),Qingting Hu,Shixia Huang,(unknown),Patrick E. Fields,Nikki Cheng	52
12	Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes 2018 ·Cancer Research ·Wen Bu,Zhenyu Liu,Weiyu Jiang,Chandandeep Nagi,Shixia Huang,Dean P. Edwards,Eunji Jo,Qianxing Mo,Chad J. Creighton,Susan G. Hilsenbeck,Andrew D. Leavitt,Michael T. Lewis,Stephen T.C. Wong,Yi Li	31
13	AIMp1 Potentiates TH1 Polarization and Is Critical for Effective Antitumor and Antiviral Immunity 2018 ·Frontiers in Immunology ·Dan Liang,Lin Tian,Ran You,Matthew M. Halpert,Vanaja Konduri,(unknown),Silke Paust,Doyeun Kim,Sung‐Hoon Kim,(unknown),Shixia Huang,Xiang Zhang,Farrah Kheradmand,David B. Corry,Brian E. Gilbert,Jonathan M. Levitt,William K. Decker	25
14	Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer 2017 ·Cancer Discovery ·Svasti Haricharan,(unknown),Purba Singh,Kimberly R. Holloway,Meenakshi Anurag,(unknown),(unknown),Jonathan T. Lei,Vera J. Suman,Kelly K. Hunt,John A. Olson,Jeremy Hoog,Shunqiang Li,Shixia Huang,Dean P. Edwards,Shyam M. Kavuri,Matthew N. Bainbridge,X. Cynthia,Matthew J. Ellis	50
15	Generation of an in vitro 3D PDAC stroma rich spheroid model 2016 ·Biomaterials ·Matthew J. Ware,Vazrik Keshishian,Justin J. Law,Jason Ho,(unknown),Paul Rees,(unknown),Mohammad Sayeeduddin,Rosa F. Hwang,Kimal Rajapakshe,Cristian Coarfa,Shixia Huang,Dean P. Edwards,Stuart J. Corr,Biana Godin,Steven A. Curley	113
16	Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer 2011 ·Oncogene ·Wen Bu,Jun Chen,(unknown),Shixia Huang,Chad J. Creighton,Jian Huang,Gary C. Chamness,Susan G. Hilsenbeck,Dennis R. Roop,Andrew D. Leavitt,Yi Li	43
17	Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function 2008 ·Cancer Research ·Suleiman Massarweh,C. Kent Osborne,Chad J. Creighton,Lanfang Qin,Anna Tsimelzon,Shixia Huang,Heidi L. Weiss,Mothaffar F. Rimawi,Rachel Schiff	375
18	Development of Resistance to Targeted Therapies Transforms the Clinically Associated Molecular Profile Subtype of Breast Tumor Xenografts 2008 ·Cancer Research ·Chad J. Creighton,Suleiman Massarweh,Shixia Huang,Anna Tsimelzon,Susan G. Hilsenbeck,C. Kent Osborne,Jiang Shou,Luca Malorni,Rachel Schiff	101
19	Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1transgenic mice 2005 ·Genome biology ·Shixia Huang,Yi Li,Yidong Chen,Katrina Podsypanina,Mario Chamorro,Adam B. Olshen,Kartiki V. Desai,Anne Tann,David Petersen,Jeffrey E. Green,Harold Varmus	37
20	Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations 2005 ·Oncogene ·Xiaomei Zhang,Katrina Podsypanina,Shixia Huang,Syed K. Mohsin,Gary C. Chamness,Sarah Hatsell,Pamela Cowin,Rachel Schiff,Yi Li	42

About Shixia Huang

Shixia Huang is a scholar working on Oncology, Molecular Biology and Cancer Research, having authored 70 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (14 papers), Epigenetics and DNA Methylation (6 papers) and Wnt/β-catenin signaling in development and cancer (6 papers). The work is most often cited by research in Oncology (1.3k citations), Aging (80 citations) and Cancer Research (651 citations). Shixia Huang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Chad J. Creighton, Joiner Cartwright, Russell M. Lebovitz, Ning Lü, Hannes Vogel, Henggui Zhang, Martin M. Matzuk, Anna Tsimelzon, C. Kent Osborne and Yi Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact